ARHS

Arhaus, Inc.

54
Fundamentals52/ 100
Valuation26/ 100
Upside potential47/ 100
Risk potential38/ 100

ARHS's outlook is improving, though it still trails on the overall score.

NIO

NIO Inc.

56
Fundamentals77/ 100
Valuation50/ 100
Upside potential58/ 100
Risk potential27/ 100

NIO has a slight edge over ARHS overall, supported by stronger fundamentals and stronger valuation.

ARHS Fundamentals

MetricStatus
Stable
Stable
Healthy
Strong

ARHS's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.

NIO Fundamentals

MetricStatus
Strong
Stable
Stable
Unavailable

NIO's revenue is currently strong, and its profitability and cash flow are stable. There isn't enough data to rate its balance sheet.

ARHS PE Valuation

CHEAPFAIREXPENSIVE8.6x17x26x34x
CHEAPFAIREXPENSIVE8.6x17x26x34x
LevelPEPriceVs current
Cheap10x$4.81-64%
Fair18x$8.20-39%
Expensive22x$10.24-24%
Forward24x$13.52—
Current29x$13.52—

Historical ranges are pointers, not guarantees.

ARHS's PE is in its expensive range at 29x. If earnings grow as analysts expect, today's price would be 24x next year's earnings.

NIO PE Valuation

NIO has no meaningful PE right now: it lost money over the past year.

ARHS Forward outlook

MetricOutlook
Improving
Strong growth
Growth
Improving
Limited
Low

Analysts expect earnings and revenue growth for ARHS, with profitability improving. However, they disagree widely on these estimates.

NIO Forward outlook

MetricOutlook
--
Losses shrinking
Growth
Strongly improving
Limited
Moderate

Analysts expect NIO's losses to shrink, with revenue growing.

ARHS Risk to reward

ScenarioChangePrice
Upside+34%$18.11
Downside-38%$8.37

Calculated from the latest close: $13.52 on Nov 12.

ARHS trails NIO on modeled risk to reward, with less potential upside and more potential downside.

NIO Risk to reward

ScenarioChangePrice
Upside+38%$4.21
Downside-27%$2.22

Calculated from the latest close: $3.05 on Nov 12.

NIO has a better modeled risk to reward balance than ARHS, with more potential upside and less potential downside.

ARHS Earnings Per Share

Q4 2023: $0.89Q1 2024: $0.76Q2 2024: $0.63Q3 2024: $0.56Q4 2024: $0.49Q1 2025: $0.41Q2 2025: $0.50Q3 2025: $0.52Q4 2025: $0.48Q1 2026: $0.47Q2 2026: $0.50Q3 2026: $0.46Forward: $0.56
Q4 2023: $0.89Q1 2024: $0.76Q2 2024: $0.63Q3 2024: $0.56Q4 2024: $0.49Q1 2025: $0.41Q2 2025: $0.50Q3 2025: $0.52Q4 2025: $0.48Q1 2026: $0.47Q2 2026: $0.50Q3 2026: $0.46Forward: $0.56
QuarterTTM EPSYoY
Forward$0.56+22%
Q3 2026$0.46-12%
Q2 2026$0.500%
Q1 2026$0.47+15%
Q4 2025$0.48-2%
Q3 2025$0.52-7.1%
Q2 2025$0.50-21%
Q1 2025$0.41-46%
Q4 2024$0.49-45%

ARHS has the edge over NIO on earnings quality, reporting a profit while its opponent remains loss making.

NIO Earnings Per Share

Q3 2023: $-1.93Q4 2023: $-1.87Q1 2024: $-1.82Q2 2024: $-1.64Q3 2024: $-1.61Q4 2024: $-1.66Q1 2025: $-1.76Q2 2025: $-1.74Q3 2025: $-1.59Q4 2025: $-1.06Q1 2026: $-0.60Q2 2026: $-0.29
Q3 2023: $-1.93Q4 2023: $-1.87Q1 2024: $-1.82Q2 2024: $-1.64Q3 2024: $-1.61Q4 2024: $-1.66Q1 2025: $-1.76Q2 2025: $-1.74Q3 2025: $-1.59Q4 2025: $-1.06Q1 2026: $-0.60Q2 2026: $-0.29
QuarterTTM EPSYoY
Q2 2026-$0.29+$1.45
Q1 2026-$0.60+$1.16
Q4 2025-$1.06+$0.60
Q3 2025-$1.59+$0.02
Q2 2025-$1.74-$0.10
Q1 2025-$1.76+$0.06
Q4 2024-$1.66+$0.21
Q3 2024-$1.61+$0.32

NIO is still losing money, but far less than before: $0.29 per share over the past year, against $1.93 at its worst in late 2023.

ARHS Quarterly Revenue

Q4 2023: $344MQ1 2024: $295MQ2 2024: $310MQ3 2024: $319MQ4 2024: $347MQ1 2025: $311MQ2 2025: $358MQ3 2025: $345MQ4 2025: $365MQ1 2026: $314MQ2 2026: $385MQ3 2026: $368M
Q4 2023: $344MQ1 2024: $295MQ2 2024: $310MQ3 2024: $319MQ4 2024: $347MQ1 2025: $311MQ2 2025: $358MQ3 2025: $345MQ4 2025: $365MQ1 2026: $314MQ2 2026: $385MQ3 2026: $368M
QuarterRevenueYoY
Q3 2026$368.1M+6.8%
Q2 2026$384.9M+7.4%
Q1 2026$314.3M+0.9%
Q4 2025$364.8M+5.1%
Q3 2025$344.6M+8%
Q2 2025$358.4M+16%
Q1 2025$311.4M+5.5%
Q4 2024$347M+0.9%

ARHS's revenue has grown year over year for eight quarters in a row: $368M last quarter, up 6.8% from the same quarter a year ago.

NIO Quarterly Revenue

Q3 2023: $2.9BQ4 2023: $2.6BQ1 2024: $1.5BQ2 2024: $2.6BQ3 2024: $2.8BQ4 2024: $3BQ1 2025: $1.8BQ2 2025: $2.9BQ3 2025: $3.3BQ4 2025: $5.2BQ1 2026: $3.8BQ2 2026: $4.8B
Q3 2023: $2.9BQ4 2023: $2.6BQ1 2024: $1.5BQ2 2024: $2.6BQ3 2024: $2.8BQ4 2024: $3BQ1 2025: $1.8BQ2 2025: $2.9BQ3 2025: $3.3BQ4 2025: $5.2BQ1 2026: $3.8BQ2 2026: $4.8B
QuarterRevenueYoY
Q2 2026$4.8B+69%
Q1 2026$3.8B+112%
Q4 2025$5.2B+76%
Q3 2025$3.3B+17%
Q2 2025$2.9B+9%
Q1 2025$1.8B+21%
Q4 2024$3B+15%
Q3 2024$2.8B-2.1%

NIO's revenue has grown year over year for seven quarters in a row: $4.8B last quarter, up 69% from the same quarter a year ago.

ARHS Free Cash Flow

Q4 2023: −$14MQ1 2024: $11MQ2 2024: $11MQ3 2024: $5MQ4 2024: $13MQ1 2025: $19MQ2 2025: $21MQ3 2025: $28MQ4 2025: −$9MQ1 2026: −$27MQ2 2026: $48MQ3 2026: $92M
Q4 2023: −$14MQ1 2024: $11MQ2 2024: $11MQ3 2024: $5MQ4 2024: $13MQ1 2025: $19MQ2 2025: $21MQ3 2025: $28MQ4 2025: −$9MQ1 2026: −$27MQ2 2026: $48MQ3 2026: $92M
QuarterFree cash flowYoY
Q3 2026$91.9M+228%
Q2 2026$48.3M+131%
Q1 2026-$26.6M-241%
Q4 2025-$8.8M-168%
Q3 2025$28M+509%
Q2 2025$20.9M+86%
Q1 2025$18.9M+73%
Q4 2024$13M+$26.8M

ARHS has the edge over NIO on cash flow, with more consistent year-over-year improvement.

NIO Free Cash Flow

Q3 2023: --Q4 2023: $137MQ1 2024: $0Q2 2024: −$2.2BQ3 2024: $0Q4 2024: −$391MQ1 2025: $0Q2 2025: −$2.1BQ3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Q3 2023: --Q4 2023: $137MQ1 2024: $0Q2 2024: −$2.2BQ3 2024: $0Q4 2024: −$391MQ1 2025: $0Q2 2025: −$2.1BQ3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
QuarterFree cash flowYoY
Q2 2026$0+$2.1B
Q1 2026$0$0
Q4 2025$0+$391.3M
Q3 2025$0$0
Q2 2025-$2.1B+$73.9M
Q1 2025$0$0
Q4 2024-$391.3M-386%
Q2 2024-$2.2B+$337.9M

NIO's free cash flow was $0 over the past year, against −$2.5B the year before.

ARHS Total Shares

Q4 2023: 140MQ1 2024: 141MQ2 2024: 141MQ3 2024: 141MQ4 2024: 141MQ1 2025: 141MQ2 2025: 141MQ3 2025: 142MQ4 2025: 141MQ1 2026: 142MQ2 2026: 142MQ3 2026: 142M
Q4 2023: 140MQ1 2024: 141MQ2 2024: 141MQ3 2024: 141MQ4 2024: 141MQ1 2025: 141MQ2 2025: 141MQ3 2025: 142MQ4 2025: 141MQ1 2026: 142MQ2 2026: 142MQ3 2026: 142M
PeriodChange %Net change
Quarterly+0.3%+467K shares
1 year+0.4%+598K shares
3 years+1.5%+2.1M shares
5 years+27%+30.2M shares
Available history+401%+114M shares

ARHS has the edge over NIO on shareholder dilution, with a more favorable share count trend.

NIO Total Shares

Q3 2023: 1.7BQ4 2023: 1.8BQ1 2024: 2BQ2 2024: 2BQ3 2024: 2.1BQ4 2024: 2.1BQ1 2025: 2.1BQ2 2025: 2.2BQ3 2025: 2.4BQ4 2025: 2.5BQ1 2026: 2.5BQ2 2026: 2.5B
Q3 2023: 1.7BQ4 2023: 1.8BQ1 2024: 2BQ2 2024: 2BQ3 2024: 2.1BQ4 2024: 2.1BQ1 2025: 2.1BQ2 2025: 2.2BQ3 2025: 2.4BQ4 2025: 2.5BQ1 2026: 2.5BQ2 2026: 2.5B
PeriodChange %Net change
Quarterly+0.6%+15.6M shares
1 year+12%+267M shares
3 years+51%+844M shares
5 years+60%+933M shares
Available history+143%+1.5B shares

NIO has 2.5B diluted shares, up 12% from a year ago.

ARHS Net Leverage

Q4 2023: -1.2xQ1 2024: -1.4xQ2 2024: -1.2xQ3 2024: -1.3xQ4 2024: -1.6xQ1 2025: -1.9xQ2 2025: -1.7xQ3 2025: -1.8xQ4 2025: -1.9xQ1 2026: -1.3xQ2 2026: -1.6xQ3 2026: -2.3x
Q4 2023: -1.2xQ1 2024: -1.4xQ2 2024: -1.2xQ3 2024: -1.3xQ4 2024: -1.6xQ1 2025: -1.9xQ2 2025: -1.7xQ3 2025: -1.8xQ4 2025: -1.9xQ1 2026: -1.3xQ2 2026: -1.6xQ3 2026: -2.3x
QuarterNet LeverageStatus
Q3 2026-2.3xNet Cash
Q2 2026-1.6xNet Cash
Q1 2026-1.3xNet Cash
Q4 2025-1.9xNet Cash
Q3 2025-1.8xNet Cash
Q2 2025-1.7xNet Cash
Q1 2025-1.9xNet Cash
Q4 2024-1.6xNet Cash

ARHS has more cash than debt.

NIO Net Leverage

NIO's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.

ARHS Weekly Momentum

MetricValueStatus
RSI69.0Neutral
Stochastic90.6Overbought

ARHS's weekly RSI is 69 (neutral) and its Stochastic is 91 (overbought).

NIO Weekly Momentum

MetricValueStatus
RSI30.7Neutral
Stochastic6.9Oversold

NIO's weekly RSI is 31 (neutral) and its Stochastic is 7 (oversold).

ARHS PE vs Consumer Cyclical Sector

MetricARHSSector medianRelative
PE29x18x63% above
PE %965640 pts above

ARHS is trading at 29x earnings, a 63% premium to the Consumer Cyclical sector's median of 18x.

NIO PE vs Consumer Cyclical Sector

NIO has no meaningful PE right now: it lost money over the past year.

ARHS Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$11.418% above
20 week MA$9.6740% above
50 week MA$8.9751% above
100 week MA$9.4144% above
200 week MA$10.529% above

ARHS has the edge over NIO on trend strength, trading above more of its moving averages.

NIO Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$3.369.2% below
20 week MA$4.0124% below
50 week MA$4.8137% below
100 week MA$4.8537% below
200 week MA$6.0349% below

NIO is in a downtrend: it's below all five of its weekly moving averages, and 49% below its 200-week average.

ARHS Yearly ROI

YearStart priceEnd priceROI
2021$12.2$10.4-15%
2022$10.4$9.24-11%
2023$9.24$11.9+28%
2024$11.9$9.26-22%
2025$9.26$11.7+27%
2026 YTD$11.7$13.5+15%

ARHS has the edge over NIO on returns for 2026, with the stronger performance.

NIO Yearly ROI

YearStart priceEnd priceROI
2020$2.42$45.8+1791%
2021$45.8$30.5-33%
2022$30.5$11.0-64%
2023$11.0$9.07-17%
2024$9.07$4.48-51%
2025$4.48$5.10+14%
2026 YTD$5.10$3.05-40%

NIO's yearly returns have swung widely, from +1791% in 2020 to −64% in 2022. It's down 40% so far in 2026.

Give your agent the market.

Get API key